PuSH - Publication Server of Helmholtz Zentrum München

Schmidt, S. ; Luecken, M. ; Trümbach, D. ; Hembach, S. ; Niedermeier, K.M. ; Wenck, N. ; Pflügler, K. ; Stautner, C. ; Böttcher, A. ; Lickert, H. ; Ramirez Suastegui, C. ; Ahmad, R.* ; Ziller, M.J.* ; Fitzgerald, J.C.* ; Ruf, V.* ; van de Berg, W.D.J.* ; Jonker, A.J.* ; Gasser, T.* ; Winner, B.* ; Winkler, J.* ; Weisenhorn, D.M. ; Giesert, F. ; Theis, F.J. ; Wurst, W.

Primary cilia and SHH signaling impairments in human and mouse models of Parkinson's disease.

Nat. Commun. 13:4819 (2022)
Publ. Version/Full Text Research data DOI PMC
Open Access Gold
Creative Commons Lizenzvertrag
Parkinson's disease (PD) as a progressive neurodegenerative disorder arises from multiple genetic and environmental factors. However, underlying pathological mechanisms remain poorly understood. Using multiplexed single-cell transcriptomics, we analyze human neural precursor cells (hNPCs) from sporadic PD (sPD) patients. Alterations in gene expression appear in pathways related to primary cilia (PC). Accordingly, in these hiPSC-derived hNPCs and neurons, we observe a shortening of PC. Additionally, we detect a shortening of PC in PINK1-deficient human cellular and mouse models of familial PD. Furthermore, in sPD models, the shortening of PC is accompanied by increased Sonic Hedgehog (SHH) signal transduction. Inhibition of this pathway rescues the alterations in PC morphology and mitochondrial dysfunction. Thus, increased SHH activity due to ciliary dysfunction may be required for the development of pathoetiological phenotypes observed in sPD like mitochondrial dysfunction. Inhibiting overactive SHH signaling may be a potential neuroprotective therapy for sPD.
Impact Factor
Scopus SNIP
Scopus
Cited By
Altmetric
17.694
3.341
1
Tags
Annotations
Special Publikation
Hide on homepage

Edit extra information
Edit own tags
Private
Edit own annotation
Private
Hide on publication lists
on hompage
Mark as special
publikation
Publication type Article: Journal article
Document type Scientific Article
Language english
Publication Year 2022
HGF-reported in Year 2022
ISSN (print) / ISBN 2041-1723
e-ISSN 2041-1723
Quellenangaben Volume: 13, Issue: 1, Pages: , Article Number: 4819 Supplement: ,
Publisher Nature Publishing Group
Publishing Place London
Reviewing status Peer reviewed
POF-Topic(s) 30204 - Cell Programming and Repair
30205 - Bioengineering and Digital Health
30201 - Metabolic Health
30203 - Molecular Targets and Therapies
Research field(s) Genetics and Epidemiology
Enabling and Novel Technologies
Helmholtz Diabetes Center
PSP Element(s) G-500500-001
G-503800-001
G-502300-001
G-506900-001
Scopus ID 85135989400
PubMed ID 35974013
Erfassungsdatum 2022-09-19